P632 Etrasimod induction therapy in moderately to severely active Crohn’s disease: results from a phase 2, randomised, double-blind substudy

Geert D’Haens, Séverine Vermeire, Marla C. Dubinsky et al.|Journal of Crohn s and Colitis|2023

Cited by 20